 |
Community and collaboration are at the heart of the Charing Cross Symposium. We want to recognise our top contributors and delegates who competed and showed their expertise in competitions, who are all vital members of the CX community!
Tilo Kölbel (vascular surgeon from Hamburg, Germany, and a member of the Executive Board for the Aortic Programme) makes the case for moving images that will “easily […]
Manj Gohel (Cambridge, UK) and member of the Venous Executive Board parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM programme, SAVVE trial and SYNCHRONOUS trial, which will all present results for the very first time to an international audience at the Charing Cross International Symposium 2024 […]
No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence
Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results of this long-awaited, only fully publicly funded randomised controlled trial (RCT) at CX 2024 (23–25 April, London, UK).
| Filmed in the newly completed CX Studio, CX Chair Professor Roger Greenhalgh (London, UK), outlines the plans for CX 2024. Now in its 46th year, the Charing Cross Symposium continues to champion world-class education, innovation and evidence and opens its doors to the global vascular and endovascular community.
Don’t miss […] |
What to Expect In-Person @ CX 2024
I attend CX to network with international colleagues in the field of vascular surgery. The best part of CX was seeing my colleagues again in-person after the pandemic years.
The best thing for me about Charing Cross was the opportunity to deal hands-on with new technologies.
The IT […]
Abstract submissions for CX 2024 are now open! We are inviting senior and trainee clinicians working in the vascular and endovascular field to submit abstracts to be considered for in-person presentations and electronic posters in the CX 2024 Vascular & Endovascular Controversies Update, in-person and virtual from London, UK, 23-25 April 2024 (Tuesday to […]